| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b1c7560aa50b0da1769cd5b6f735b69 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7012 |
| filingDate |
2008-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf87071109b562db3bcd5e3acd5bcac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5772c8b072c16ec10eb262e3102ca68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c29cf81ef339b5193468bb93d6ad5b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1aabfd39fa7ef38a7a19381e0b1e5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27f8c21ee1f9e5116ae4a8f647e66a5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_630ebcf0edcacfd332c443a97c1cd30c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79c91fc0027b50032a0c794b8a222778 |
| publicationDate |
2009-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-200902068-A |
| titleOfInvention |
GLP-1 peptide having sugar chain attached thereto |
| abstract |
Disclosed is a GLP-1 peptide having a sugar chain attached thereto, which has a longer blood half-life compared with GLP-1 and preferably also has a high blood glucose level lowering activity. Specifically disclosed is a GLP-1 peptide having a sugar chain attached thereto and having a GLP-1 activity, which is produced by substituting at least one amino acid residue in any one of the following components (a) to (c) by an amino acid residue having a sugar chain attached thereto: (a) GLP-1; (b) a peptide having the deletion, substitution or addition of one or several amino acid residues in GLP-1; and (c) an analogue of GLP-1. |
| priorityDate |
2007-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |